Havrix is used to help prevent hepatitis A in adults. Learn about side effects, interactions and indications.
Using three doses of 25 U/dose of VAQTA or 720 EU/dose of HAVRIX at 0, 1 and 6 m did not produce any clinically evaluable advantage over the two dose regimen for either vaccine. No significant adverse events were observed using either vaccine. In summary, both vaccines have similar ...
Adults Description: HAVRIX is available in prefilled disposable Tip-Lok syringes (packaged without needles) (Preservative Free Formulation).1 Pediatric/adolescent dose (persons 12 months through 18 years of age): 720 EL.U./0.5 mL1 Recommended dosing: A single 0.5-mL dose and a 0.5-mL booster...
Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: Safety and immunogenicity of a phase 1/2 clinical trial Dose-sparing strategies and new production technologies will be necessary to produce adequate supplies of vaccines for pandemic influenza. One approach is ... W ...
Antibody persistence in two cohorts of adults, who received inactivated hepatitis A (HAV) vaccine (1440El.U;Havrix; GSK Vaccines) according to a 0–6 or 0–12 month schedule in 1992–1993, has been measured annually. After 20 years, >97% of the subjects in both studies were seropositive...